MiR-29a: a potential therapeutic target and promising biomarker in tumors

J Wang, Q Zhang, D Wang, W Yan, H Sha… - Bioscience …, 2018 - portlandpress.com
MiRNAs, small non-coding RNA molecules, were recognized to be associated with the
incidence and development of diverse neoplasms. MiRNAs were small non-coding RNAs …

Regulating Cdc42 and its signaling pathways in cancer: small molecules and MicroRNA as new treatment candidates

XH Xiao, LC Lv, J Duan, YM Wu, SJ He, ZZ Hu… - Molecules, 2018 - mdpi.com
Despite great improvements in the diagnosis and treatment of neoplasms, metastatic
disease is still the leading cause of death in cancer patients, with mortality rates still rising …

Cdc42: a novel regulator of insulin secretion and diabetes-associated diseases

QY Huang, XN Lai, XL Qian, LC Lv, J Li, J Duan… - International journal of …, 2019 - mdpi.com
Cdc42, a member of the Rho GTPases family, is involved in the regulation of several cellular
functions including cell cycle progression, survival, transcription, actin cytoskeleton …

Detection of a miRNA biomarker for cancer diagnosis using SERS tags and magnetic separation

K Treerattrakoon, P Roeksrungruang, T Dharakul… - Analytical …, 2022 - pubs.rsc.org
Detection of miR-29a, a biomarker of cancers, using SERS tags and magnetic separation is
described. The assay was designed to detect the miR-29a sequence by taking the …

Correlation between circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-small-cell Lung Cancer patients

M Bache, F Kadler, O Struck, D Medenwald… - International Journal of …, 2023 - mdpi.com
Despite the success of current therapy concepts, patients with advanced non-small-cell lung
cancer (NSCLC) still have a very poor prognosis. Therefore, biological markers are urgently …

MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma

SM Son, J Yun, DW Kim, YS Jung, SB Han, YH Lee… - BMC cancer, 2023 - Springer
Abstract Background Non-coding microRNAs (miRNAs) play critical roles in tumor
progression and hold great promise as therapeutic agents for multiple cancers. MicroRNA …

MicroRNA-29a functions as a tumor suppressor and increases cisplatin sensitivity by targeting NRAS in lung cancer

X Liu, X Lv, Q Yang, H Jin, W Zhou… - Technology in cancer …, 2018 - journals.sagepub.com
MicroRNAs have been reported to play an important role in diverse biological processes
and progression of various cancers. MicroRNA-29a has been observed to be …

Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients

W Liu, Y Xu, H Guan, H Meng - Cancer Biomarkers, 2018 - content.iospress.com
BACKGROUND: Breast cancer remains the most invasive female malignancy worldwide.
Functional role of microRNA-940 (miR-940) have been investigated in various cancer. The …

Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1

Y Hu, L Xie, J Yu, H Fu, D Zhou, H Liu - Molecular Medicine, 2020 - Springer
Background The main features of bronchopulmonary dysplasia (BPD) are alveolar
simplification, pulmonary growth arrest, and abnormal lung function. Multiple studies have …

[PDF][PDF] RETRACTED ARTICLE: MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis

P Nan, Y Niu, X Wang, Q Li - OncoTargets and therapy, 2019 - Taylor & Francis
Nan P, Niu Y, Wang X, Li Q. Onco Targets Ther. 2019; 12: 6917-6925. We, the Editors and
Publisher of OncoTargets and Therapy, have retracted the following article. Since …